GL1X · GenesisL1 explorer

MolNFT v1 · #32959 · protein

Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design

2C5V · Cell division protein kinase 2: “Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design”. X-ray diffraction, 2 ligands (CK4, NH2), 15 pockets (best druggability 0.81). MolNFT v1 #32959 on…

PDB
2C5V
Type
protein
Length
1,124 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2; Cyclin A2; Ala-ala-aba-arg-ser-leu-ile-pff-NH2
EC
2.7.1.37
UniProt
P24941, P20248
Ligands
CK4, NH2
Pockets
15 · best druggability 0.81

Structure

x-ray diffraction · 3 distinct chains · 48% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CCell division protein kinase 2 (EC 2.7.1.37)protein29634% helix, 16% strandP24941
B, DCyclin A2protein25866% helix, 0% strandP20248
F, HAla-ala-aba-arg-ser-leu-ile-pff-NH2protein80% helix, 0% strand—

Ligands and binding sites

  • CK4 · 4-(2,4-dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyrimidin-2-amine · ligand · 2 copies · chains A, C
  • NH2 · Amino group · ion · 2 copies · chains F, D, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11350.810.9825empty
21320.800.9824empty
38830.770.8087empty
42000.680.8626CK4
52060.660.8423CK4

Interfaces

7 interfaces between chains.

  • A–B · 1659 Ų buried · 17 hydrogen bonds · protein-protein
  • C–D · 1607 Ų buried · 23 hydrogen bonds · protein-protein
  • B–F · 553 Ų buried · 11 hydrogen bonds · protein-protein
  • D–H · 520 Ų buried · 7 hydrogen bonds · protein-protein
  • B–C · 477 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (nonstandard).

Compared structures

  • 2C5V · Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug… · the same entry in another collection · chain H against H, TM-score 1.00
  • P20248 · AlphaFold monomer V2.0 prediction for cyclin-A2 (P20248) · a predicted model of the same protein · chain B against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain C against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.